Hepcidin and Anemia: A Tight Relationship

Area of Science:

• Hematology
• Iron Metabolism
• Endocrinology

Background:

• Hepcidin is the primary regulator of systemic iron homeostasis, influencing iron absorption and recycling.
• Hepcidin levels directly impact erythropoiesis; high levels cause iron restriction, while low levels promote red blood cell production.

Purpose of the Study:

• To explore the role of hepcidin dysregulation in various anemia types.
• To discuss potential therapeutic strategies targeting hepcidin for anemia treatment.

Main Methods:

• Review of literature on hepcidin's role in iron metabolism and erythropoiesis.
• Analysis of conditions with hepcidin deregulation, including IRIDA, anemia of inflammation, and iron loading anemias.
• Examination of preclinical and clinical approaches targeting hepcidin.

Main Results:

• Inappropriately high hepcidin causes iron-restricted erythropoiesis in IRIDA, anemia of inflammation, and hepcidin-producing adenomas.
• Ineffective erythropoiesis in iron loading anemias leads to hepcidin suppression and iron overload.
• Animal models show iron restriction ameliorates anemia and iron phenotypes.

Conclusions:

• Hepcidin antagonism may benefit anemia of inflammation and IRIDA.
• Hepcidin agonism could improve ineffective erythropoiesis.
• Targeting hepcidin presents a promising therapeutic avenue for diverse anemias.